Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study

Title:	EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study
Authors:	Martins-Branco, Diogo^Aff1; Lobo-Martins, Soraia^Aff1; Aftimos, Philippe^Aff2; Pereira, Bernardo^Aff3; Vasconcelos de Matos, Leonor^Aff4; Fernandes, Leonor^Aff5; Campôa, Elsa^Aff6; Nader-Marta, Guilherme^Aff1; Moreau, Michel^Aff7; Taylor, Donatienne^Aff8; Duhoux, Francois P.^Aff9; Simões, Pedro^Aff10; Garcia, Ana Rita^Aff11; Patel, Vanessa^Aff12; Confente, Caterina^Aff13; Alpuim Costa, Diogo^{Aff14, Aff15}; Pereira, José^Aff16; Santos, Catarina^Aff15; Paesmans, Marianne^Aff7; Sarmento, Frederico^Aff3; Gantes Padrão, Teresa^Aff4; Simão, Diana^Aff5; Bandarra, Daniel^Aff6; Sousa, Berta^Aff4; Brito, Margarida^Aff3; Gombos, Andrea^Aff2; Ameye, Lieveke^Aff7; de Azambuja, Evandro^{Aff1, Aff2, IDs10549026080125_cor1}
Source:	Breast Cancer Research and Treatment. 218(1)
Database:	Springer Nature Journals